LENZ Therapeutics, Inc. (LENZ) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LENZ Revenue Growth
LENZ Revenue Analysis (2019–2025)
As of May 8, 2026, LENZ Therapeutics, Inc. (LENZ) generated trailing twelve-month (TTM) revenue of $19.1 million. The most recent quarter (Q4 2025) recorded $1.6 million in revenue, down 87.3% sequentially.
Looking at the longer-term picture, LENZ's historical revenue data shows a 3-year CAGR of +8.4%. The company achieved its highest annual revenue of $19.1 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including PRPH (-91.6% YoY), NKTR (-43.9% YoY), and AEYE (+14.5% YoY). Compare LENZ vs PRPH →
LENZ Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LENZCurrent | $19M | - | - | -477.5% | |
 PRPH | $7M | -91.6% | -7.3% | -570.6% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 AEYE | $40M | +14.5% | +14.5% | -7.9% |
LENZ Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $19.1M | - | $18.7M | 97.8% | $-91,138,000 | -477.5% |
| 2024 | $0 | - | $-58,000 | - | $-58,610,000 | - |
| 2023 | $0 | -100.0% | $0 | - | $-72,429,000 | - |
| 2022 | $15.0M | - | $15.0M | 100.0% | $-10,483,000 | -69.9% |
| 2021 | $0 | - | $-734,000 | - | $-60,443,000 | - |
| 2020 | $0 | - | $-121,000 | - | $-13,500,000 | - |
| 2019 | $0 | - | $0 | - | $-29,000 | - |
See LENZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LENZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LENZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLENZ — Frequently Asked Questions
Quick answers to the most common questions about buying LENZ stock.
Is LENZ's revenue growth accelerating or slowing?
LENZ TTM revenue: $19M. YoY growth: N/A. 5-year CAGR: N/A.
What is LENZ's long-term revenue growth rate?
LENZ Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is LENZ's revenue distributed by segment?
LENZ reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.